Quantcast

Keystone Today

Saturday, November 2, 2024

FDA conducted lowest number of inspections on Drugs companies in Pennsylvania during Q3

Webp feai7bphhdls0aqws5mfv0zinhxh

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website

In the third quarter of 2024, three Drugs companies received three FDA inspections in Pennsylvania, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in Pennsylvania, equalling 5.4% of all inspections in the third quarter of 2024.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Pennsylvania During Q3
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products9----
Compliance: Devices21--
Drug Quality Assurance21--
Food Composition, Standards, Labeling and Econ6----
Foodborne Biological Hazards217--
Human Cellular, Tissue, and Gene Therapies41--
Monitoring of Marketed Animal Drugs, Feed, and Devices51--
Postmarket Assurance: Devices1----
Technical Assistance: Food and Cosmetics5----

MORE NEWS